normax.ai
  • Home
  • About Us
  • Virtual Tumor Board
  • EARTh
  • News
Select Page

12. WHAT mRNA Vaccines are in development by Normax?

Aug 31, 2022

With an early stage budget of €25,000,000 each, Normax is currently developing mRNA vaccines for:

  • SARS-C0V-2
  • Tuberculosis (TB)
  • HIV
  • Malaria
VIDEO: mRNA Vaccines in Development by Normax (1:00)

Recent Posts

  • BiocommAI Announces Participation In U.S. Department Of Commerce Consortium Dedicated To AI Safety

Recent Comments

No comments to show.
Copyright NormaxAI 2024